-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Upgrades Staar Surgical to Buy, Raises Price Target to $27

Benzinga·04/09/2026 12:30:15
Listen to the news
Canaccord Genuity analyst John Young upgrades Staar Surgical (NASDAQ:STAA) from Hold to Buy and raises the price target from $22 to $27.